Feedback PLC Bleepa - revolutionising clinical messaging
July 26 2019 - 7:03AM
RNS Non-Regulatory
TIDMFDBK
Feedback PLC
26 July 2019
Feedback plc
Bleepa(TM) - revolutionising clinical messaging
New medical grade imaging app to be launched at NHS Expo on 4-5
September 2019
Cambridge, 26 July 2019: Further to the Company's strategic
review announcement on 10 July 2019, Feedback plc (AIM: FDBK,
"Feedback" or the "Company"), the specialist medical imaging
technology company, today provides an update on its new clinical
messaging product: Bleepa(TM) .
As previously announced, Feedback plans to establish a leading
role in the medical communication market. Bleepa(TM) , its new app
for clinicians, is currently in beta development and will be
formally launched at NHS Expo on 4-5 September 2019 in
Manchester.
Based on Feedback's Cadran technology, Bleepa(TM) is a secure,
encrypted medical communication tool accessible through
smartphones, tablets and desktops that facilitates rapid clinical
messaging and review of medical grade imaging for all members of a
clinical team, directly from a hospital Picture Archiving and
Communications System (PACS). Bleepa(TM) enables faster clinical
decision making between team members wherever they are,
accelerating and improving patient care.
According to an article published in BMJ Innovations, 97% of
hospital doctors routinely use WhatsApp to communicate about
patients.(1)
This increasing trend for clinicians to use personal devices to
discuss patient care and make clinical decisions is more convenient
and efficient than traditional methods of clinical communication.
However, using such methods opens doctors and their patients up to
a variety of risks.
Bleepa(TM) addresses growing concerns about these messaging
platforms not meeting diagnostics clinical standards and regarding
patient data protection. Continued use of non-specialist
communication tools could leave both hospitals and individual
clinical users significantly exposed and therefore open to the risk
of litigation.
The Directors believe Bleepa(TM) will be the only communication
tool to be a CE marked medical device. More information can be
found at www.bleepa.com.
Dr Tom Oakley, CEO of Feedback, commented:
"We are making rapid progress in the development of our new
messaging app, Bleepa(TM) . We believe that it will provide a
flexible, accurate and secure method for swift clinical decision
making, revolutionising the way in which patients receive treatment
whilst safeguarding our doctors from potential litigation. We look
forward to showcasing the finished product this September at NHS
Expo in Manchester."
(1) O'Sullivan DM, O'Sullivan E, O'Connor M, et al WhatsApp Doc?
BMJ Innovations 2017;3:238-239.
-Ends-
Enquiries:
Feedback plc +44 (0)1954 718072
Tom Oakley, CEO IR@fbk.com
Lindsay Melvin, CFO
Instinctif Partners +44 207 457 2020
Rozi Morris/Phillip Marriage Feedbackplc@instinctif.com
Notes to editors About Feedback plc
Feedback plc (AIM: FDBK) is a specialist medical imaging
technology company providing innovative software and systems,
through its fully-owned trading subsidiary, Feedback Medical
Limited. Its products advance the work of radiologists, clinicians
and medical researchers by improving workflows and giving unique
insights into diseases, particularly cancer. Feedback Medical works
with customers globally from headquarters in the internationally
renowned scientific hub of Cambridge, UK. Its proprietary
technologies are TexRAD(R) , the quantitative texture analysis tool
and Cadran, a picture archiving communication system (PACS). For
more information, see www.fbk.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NRAFQLFLKDFBBBF
(END) Dow Jones Newswires
July 26, 2019 07:03 ET (11:03 GMT)
Feedback (LSE:FDBK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Feedback (LSE:FDBK)
Historical Stock Chart
From Jul 2023 to Jul 2024